The assessment and treatment of distress in cancer patients: Overview and future directions

Minerva Psichiatrica

Volumn 49, Issue 2, 2008, Pages 129-143

  Lo, C ^a,b   Li, M ^a,b   Rodin, Gary ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Depressive disorder; Neoplasms; Quality of life

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE; DESIPRAMINE; FLUOXETINE; HYPNOTIC AGENT; KAVA; LORAZEPAM; MELATONIN; MIANSERIN; PAROXETINE; VALERIAN;

ANXIETY DISORDER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; COGNITIVE THERAPY; DISTRESS SYNDROME; EMERGENCY HEALTH SERVICE; GROUP THERAPY; GUIDED IMAGERY; HUMAN; INSOMNIA; INTERNET; MAJOR DEPRESSION; NEOPLASM; PATIENT ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; TREATMENT DURATION; WELLBEING;

EID: 52649119661     PISSN: 03911772     EISSN: 18271731     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. Qaseem A, Snow V, Shekelle P, Casey DE Jr, Cross JT Jr, Owens DK et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Int Med 2008;148:141-6.
2. van Halteren HK, Bongaerts GP, Wagener DJ. Cancer and psychosocial distress. Lancet 2004;364:824-5.
3. Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symp Manage 1995;10:131-41.
4. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2002;94:2719-27.
5. Faller H, Bulzebruck H, Drings P, Lang J. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry 1999;56:756-62.
6. Chochinov HM, Wilson KG, Enns M, Mowchun N, Lander S, Levitt M et al. Desire for death in the terminally ill. Am J Psychiatry 1995;152:1185-91.
7. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet 1999;354:816-9.
8. Holland JC, Andersen B, Breitbart WS, Dabrowski M, Dudley MM, Fleishman S et al. Distress management. J Natl Compr Canc Netw 2007;5:66-98.
9. Aggen SH, Neale MC, Kendler KS. DSM criteria for major depression: evaluating symptom patterns using latent-trait item response models. Psychol Med 2005;35:475-87.
10. Horwitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press; 2007.
11. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-7.
12. Morasso G. Screening adjustment disorders related to mastectomy and its treatment. New Trends in Exp Clin Psych 1997;13:90-3.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th edition. Washington, DC: American Psychiatric Association Press; 2000.
14. Ronson A. Psychiatric disorders in oncology: recent therapeutic advances and new conceptual frameworks. Curr Opin Oncol 2004;16:318-23.
15. Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer 2007;110:1665-76.
16. Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 2007;16:181-8.
17. Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 2002;43:259-81.
18. Gross AF, Smith FA, Stern TA. Is depression an appropriate response to having cancer? A discussion of diagnostic criteria and treatment decisions. Prim Care Companion J Clin Psychiatry 2007;9:382-7.
19. Miller K, Massie MJ. Depression and anxiety. Cancer J 2006;12:388-97.
20. Rodin G, Katz M, Lloyd N, Green E, Mackay JA, Wong RKS et al. Treatment of depression in cancer patients. Curr Oncol 2007;14:180-8.
21. Rowe SK, Rapaport MH. Classification and treatment of sub-threshold depression. Curr Opin Psych 2006;19:9-13.
22. Rodin G, Zimmermann C, Rydall A, Jones J, Shepherd FA, Moore M et al. The desire for hastened death in patients with metastatic cancer. J Pain Symptom Manage 2007;33:661-75.
23. Ell K, Quon B, Quinn DI, Dwight-Johnson M, Wells A, Lee PJ et al. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry 2007;29:223-31.
24. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005;62:617-27.
25. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004:57-71.
26. Jim HS, Andrykowski MA, Munster PN, Jacobsen PB. Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Ann Behav Med 2007;34:200-8.
27. Cuijpers P, Smit F, Willemse G. Predicting the onset of major depression in subjects with subthreshold depression in primary care: a prospective study. Acta Psych Scand 2004;111:133-8.
28. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1-8.
29. Grassi L, Mangelli L, Fava GA, Grandi S, Ottolini F, Porcelli P et al. Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Dis 2007;101:251-4.
30. Fava GA, Fabbri S, Sirri L, Wise TN. Psychological factors affecting medical condition: a new proposal for DSM-V. Psychosom 2007;48:103-11.
31. Sirri L, Fabbri S, Fava GA, Sonino N. New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess 2007;89:216-28.
32. Mangelli L, Fava GA, Grandi S, Grassi L, Ottolini F, Porcelli P et al. Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry 2005;66:391-4.
33. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive theory of depression. New York: Guilford Press; 1979.
34. Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 2002;36:733-42.
35. Griffith JL, Gaby L. Brief psychotherapy at the bedside: countering demoralization from medical illness. Psychosom 2005;46:109-16.
36. Baucom DH, Porter LS, Kirby JS, Gremore TM, Keefe FJ. Psychosocial issues confronting young women with breast cancer. Breast Dis 2005-2006;23:103-13.
37. Baider L, Andritsch E, Uziely B, Goldzweig G, Ever-Hadani P, Hofman G et al. Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol 2003;46:5-16.
38. Andrykowski MA, Cordova MJ, McGrath PC, Sloan DA, Kenady DE. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology 2000;9:69-78.
39. Butler LD, Koopman C, Classen C, Spiegel D. Traumatic stress, life events, and emotional support in women with metastatic breast cancer: cancer-related traumatic stress symptoms associated with past and current stressors. Health Psychol 1999;18:555-60.
40. Lewis JA, Manne SL, DuHamel KN, Vickburg SM, Bovbjerg DH, Currie V et al. Social support, intrusive thoughts, and quality of life in breast cancer survivors. J Behav Med 2001;24:231-45.
41. Kaasa S, Malt U, Hagen S, Wist E, Mourn T, Kvikstad A. Psychological distress in cancer patients with advanced disease. Radiother Oncol 1993;27:193-7.
42. Hampton MR, Frombach I. Women's experience of traumatic stress in cancer treatment. Health Care Women Int 2000;21:67-76.
43. Jacobsen PB, Sadler IJ, Booth-Jones M, Soety E, Weitzner MA, Fields KK. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psych 2002;70:235-40.
44. Manne S, Glassman M, Du Hamel K. Intrusion, avoidance, and psychological distress among individuals with cancer. Psychosom Med 2001;63:658-67.
45. Jacobsen PB, Widows MR, Hann DM, Andrykowski MA, Kronish LE, Fields KK. Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med 1998;60:366-71.
46. Smith MY, Redd WH, Peyser C, Vogl D. Post-traumatic stress disorder in cancer: a review. Psychooncology 1999;8:521-37.
47. Gurevich M, Devins GM, Wilson C, McCready D, Marmar CR, Rodin GM. Stress response syndromes in women undergoing mammography: a comparison of women with and without a history of breast cancer. Psychosom Med 2004;66:104-12.
48. Han WT, Collie K, Koopman C, Azarow J, Classen C, Morrow GR et al. Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology 2005;14:318-30.
49. Butler LD, Koopman C, Cordova MJ, Garlan RW, DiMiceli S, Spiegel D. Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosom Med 2003;65:416-26.
50. Strain JJ. Psychiatric diagnostic dilemmas in the medical setting. Aust New Zeal J Psych 2005;39:764-71.
51. Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000;284:2907-11.
52. Jones JM, Huggins MA, Rydall AC, Rodin GM. Symptomatic distress, hopelessness, and the desire for hastened death in hospitalized cancer patients. J Psychosom Res 2003;55:411-8.
53. Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995;13:748-55.
54. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psych 2003;54:283-94.
55. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immun 2006;27:24-31.
56. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:45-56.
57. Mikulincer M, Shaver PR. Attachment in adulthood - structure, dynamics, and change. New York: Guilford Press; 2007.
58. Breslau N, Davis GC, Peterson EL, Schultz LR. A second look at comorbidity in victims of trauma: the post-traumatic stress disorder-major depression connection. Biol Psych 2000;48:902-9.
59. Ronson A. Adjustment disorders in oncology: a conceptual framework to be refined. Encephale 2005;31:118-26.
60. Sulmasy DP. A biopsychosocial-spiritual model for the care of patients at the end of life. Gerontologist 2002;42:24-33.
61. World Health Organization. Palliative care. Cancer control: knowledge into action: WHO guide for effective programmes: module 5. Geneva, Switzerland: WHO Press; 2007.
62. Allan J, Barwick TA, Cashman S, Cawley JF, Day C, Douglass CW et al. Clinical prevention and population health: curriculum framework for health professions. Am J Prev Med 2004;27:471-6.
63. Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004;32:80-92.
64. Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 2002;16:81-97.
65. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
66. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-1A and -II in psychiatric outpatients. J Pers Assess 1996;67:588-97.
67. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983:13:595-605.
68. Carlson LE, Bultz BD. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003;55:403-9.
69. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998;82:1904-8.
70. Wright P, Smith A, Roberts K, Selby P, Velikova G. Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory. Br J Cancer 2007;97;1063-70.
71. Schade CP, Jones ER Jr, Wittlin BJ. A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv 1998;49:55-61.
72. Palmer SC, Coyne JC. Screening for depression in medical care. Pitfalls, alternatives, and revised priorities. J Psychosom Res 2003;54:279-87.
73. Andersen RM. Revisiting the behavioural model access to medical care, does it matter? J Health Soc Behav 1995;36:1-10.
74. Arora NK. Interacting with cancer patients: the significance of physicians' communication behaviour. Soc Sci Med 2003;57:791-806.
75. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011-5.
76. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998;16:1594-600.
77. Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RKS et al. The treatment of depression in cancer patients: A systematic review. Support Care Cancer 2007;15:123-36.
78. Kash KM, Mago R, Kunkel EJ. Psychosocial oncology: supportive care for the cancer patient. Semin Oncol 2005;32:211-8.
79. O'Donnell JF. Insomnia in cancer patients. Clin Cornerstone 2004;6 Suppl 1D:S6-14.
80. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol 2005;3:349-59.
81. Jacobsen PB, Donovan KA, Swaine ZN, Watson IS. Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. In: Change AE, Hayes DF, Pass HI, Stone RM, Ganz PA, Kinsella TJ et al., editors. Oncology: an evidence-based approach. Philadelphia, PA: Springer; 2006. p. 1552-79.
82. Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl 1985;320:85-92.
83. Fisch MJ, Loehrer PJ, Kristeller J, Passik S, Jung SH, Shen J et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003;21:1937-43.
84. Holland JC, Morrow GR, Schmale A, Derogatis L, Stefanek M, Berenson S et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 1991;9:1004-11.
85. Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MG. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998;7:291-300.
86. Pezzella G, Moslinger-Gehmayr R, Contu A. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitiptyline. Breast Cancer Res Treat 2001;70:1-10.
87. Razavi D, Allilaire JE, Smith M, Salimpour A, Verra M, Descalux B et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta. Psychiatr Scand 1996;94:205-10.
88. van Heeringen K, Zivkov M. Pharmacological treatment of depression in cancer patients: a placebo-controlled study of mianserin. Br J Psychiatry 1996;169:440-3.
89. Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psych 2006;67:288-96.
90. Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharm 2004;29:385-92.
91. Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharm Sci 2003;24:580-8.
92. Nemeroff CB. New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum Psychopharm Clin Exp 2002;17:S13-6.
93. Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat 2007. In press.
94. Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004;6 Suppl 1D:S15-S21.
95. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Onc 2005; 23:6097-106.
96. Kvale EA, Shuster JL. Sleep disturbance in supportive care of cancer: a review. J Palliat Med 2006;9:437-50.
97. Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006;10:419-29.
98. Berger AM, Parker KP, Young-McCaughan S, Mallory GA, Barsevick, AM, Beck SL et al. Sleep-wake disturbances in people with cancer and their caregivers: state of the science. One Nurs Forum 2005;32:E98-126.
99. Bhat A, Shafi F, Solh AA. Pharmacotherapy of insomnia. Exp Opin Pharmacother 2008;9:351-62.
100. Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst 2002;94:558-84.
101. Barsevick AM, Sweeney C, Haney E, Chung E. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum 2002;29:73-84.
102. Uitterhoeve RJ, Vernooy M, Litjens M, Potting K, Bensing J, De Mulder P et al. Psychosocial interventions for patients with advanced cancer - a systematic review of the literature. Br J Cancer 2004;91:1050-62.
103. Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 2006;94:372-90.
104. McQuellon RP, Wells M, Hoffman S, Craven B, Russell G, Cruz J et al. Reducing distress in cancer patients with an orientation program. Psychoocology 1998;7:207-17.
105. Sharpe M, Strong V, Allen K, Rush R, Maguire P, House A et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer 2004;90:310-3.
106. Moorey S, Greer S, Watson M, Baruch JDR, Robertson BM, Mason A et al. Adjuvant psychological therapy for patients with cancer: outcome at one year. Psychooncology 1994;3:39-46.
107. Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology 2003;12:532-46.
108. Rodgers M, Fayter D, Richardson G, Ritchie G, Lewin R, Sowden AJ. The effects of psychosocial interventions in cancer and heart disease: a review of systematic reviews [Internet]. York, UK: Centre for Reviews and Dissemination, University of York; 2005 Available from: http://www.york.ac.uk/inst/crd/pdf/ report30.pdf [cited 2008-01-29].
109. Kissane DW, Grabsch B, Clarke DM, Smith GC, Love AW, Bloch S et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007;16:277-86.
110. Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs 2005;52:315-27.
111. Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007;34: E51-9.
112. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005;23:6083-96.
113. Morin CM, Epsie CA. Insomnia: a clinician's guide to assessment and treatment. New York: Kluwer Academic/Plenum Publishers; 2003.
114. Pedis ML, Jungquist C, Smith MT, Posner D. Cognitive behavioral treatment of insomnia. New York: Springer; 2005.
115. Lepore SJ, Coyne JC. Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med 2006;32:85-92.
116. Coyne JC, Lepore SJ, Palmer SC. Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med 2006;32:104-10.
117. Coyne JC, Lepore SJ. Rebuttal: the black swan fallacy in evaluating psychological interventions for distress in cancer patients. Ann Behav Med 2006;32:115-8.
118. Andrykowski MA, Manne SL. Are psychological interventions effective and accepted by cancer patients? I. Standards and levels of evidence. Ann Behav Med 2006;32:93-7.
119. Manne SL, Andrykowski MA. Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide. Ann Behav Med 2006;32:98-103.
120. Manne SL, Andrykowski MA. Seeing the forest for the trees: a rebuttal. Ann Behav Med 2006;32:111-4.
121. Winzelberg AJ, Classen C, Alpers GW, Roberts H, Koopman C, Adams RE et al. Evaluation of an internet support group for women with primary breast cancer. Cancer 2003;97:1164-73.
122. Tan A, Zimmermann C, Rodin G. Interpersonal processes in palliative care: an attachment perspective on the patient-clinician relationship. Palliat Med 2005;19:143-50.
123. Rodin G, Walsh A, Zimmermann C, Gagliese L, Jones J, Shepherd FA et al. The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancer. Psychooncology 2007;16:1080-91.
124. Bowlby J. Attachment and loss. Vol. 1. Attachment. 2nd edition. New York: Basic Books; 1982.
125. Bowlby J. Attachment and loss. Vol. 2. Separation: anxiety and anger. New York: Basic Books; 1973.
126. Bowlby J. Attachment and loss. Vol. 3. Sadness and depression. New York: Basic Books; 1980.
127. McLean LM, Nissim R. Marital therapy for couples facing advanced cancer: case review. Palliat Support Care 2007;5:303-13.
128. Kim Y, Kashy DA, Wellisch DK, Spillers RL, Kaw C, Smith TG. Quality of life of couples dealing with cancer: dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers. Ann Behav Med. In press.
129. Kim Y, Wellisch DK, Spillers RL. Effects of psychological distress on quality of life of adult daughters and their mother with cancer. Psychooncology. 2008 [Epub ahead of print].
130. Braun M, Mikulincer M, Rydall A, Walsh A, Rodin G. Hidden morbidity in cancer: spouse caregivers. J Clin Oncol 2007;25:4829-34.
131. Johnson SM. Emotionally focused couple therapy with trauma survivors: stenghtening attachment bonds. New York: Guilford Press; 2002.